ARS Pharmaceuticals, Inc.
← Back to SPRY Overview

ARS Pharmaceuticals, Inc. (SPRY)

Revenue & Top-Line Growth

Latest Revenue

$22.7M

Financial Fundamentals

SPRYQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.02B-19.2%+184.5%0.10B+1.9%
2025-12-310.03B-13.6%-67.6%0.08B-5.5%
2025-09-300.03B+106.8%+1471.6%0.14B+5459.7%
2025-06-300.02B+97.1%+3043.4%0.11B+22367.8%
2025-03-310.01B-90.8%0.10B+971120.0%
2024-12-310.09B+4086.7%0.09B+297063.3%
2024-09-300.00B+313.6%0.00B+8460.0%
2024-06-300.00B+4900.0%0.00B+128.3%
2024-03-310.00B0.00B-98.5%
2023-12-310.00B0.00B-97.7%
2023-09-300.00B0.00B-98.6%
2023-06-300.00B-50.0%-97.8%0.00B-90.9%
2023-03-310.00B-97.0%0.00B-83.4%
2022-12-310.00B0.00B-76.1%
2022-09-300.00B-59.3%-64.2%0.00B-56.4%
2022-06-300.00B-30.0%-78.0%0.00B-43.0%
2022-03-310.00B-12.1%-68.6%0.00B+92.1%
2021-12-310.00B+42.8%0.01B
2021-09-300.00B-75.0%0.00B
2021-06-300.00B0.0%0.00B
2021-03-310.00B0.00B
2020-12-310.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B
2019-12-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.08B-5.5%
20240.09B+297063.3%
20230.00B-97.7%
20220.00B-76.1%
20210.01B-69.1%
20200.02B
20190.00B
20180.00B